Quick Answer
ENvue Medical, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $2.56 million for the year ending 2024.
- ENvue Medical, Inc. showed an increase of +12.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2023 to 2024.
- This data is from ENvue Medical, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $79.0 thousand | Q3 2019: $101.0 thousand | Q1 2020: $114.0 thousand | Q2 2020: $269.0 thousand | Q3 2020: $150.0 thousand | Q1 2021: $103.0 thousand | Q2 2021: $318.0 thousand | Q3 2021: $499.0 thousand | Q1 2022: $272.0 thousand | Q2 2022: $485.0 thousand | Q3 2022: $97.0 thousand | Q1 2023: $354.0 thousand | Q2 2023: $294.0 thousand | Q3 2023: $458.0 thousand | Q1 2024: $921.0 thousand | Q2 2024: $817.0 thousand | Q3 2024: $376.0 thousand | Q1 2025: $1.03 million | Q2 2025: $494.0 thousand | Q3 2025: $722.0 thousand.
- Over the full 7 years of available data (2018 to 2024), ENvue Medical, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 704.4%.
- Historical annual values: Fiscal year 2024: $2.56 million | Fiscal year 2023: $2.28 million | Fiscal year 2022: $752.0 thousand | Fiscal year 2021: $1.70 million | Fiscal year 2020: $623.0 thousand | Fiscal year 2019: $530.0 thousand | Fiscal year 2018: $318.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: